New findings of an Alliance Foundation Trials study show combining immunotherapy and chemotherapy before surgery improves ...
The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favorable safety profile in ...
EGFR Non-Small Cell Lung Cancer Market · GlobeNewswire Inc. The report offers comprehensive insights including market size, ...
Is Zepzelca Right for Me? To help choose the right treatment for you, your health care provider will consider what type of lung cancer you have, the treatments you have received, and whether the ...
IndyStar documented Kristy Prosser's journey, beginning just a few weeks after she was diagnosed through the completion of ...
AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.
ANKTIVA approved for patients with certain indications of non-muscle invasive bladder cancer and non-small cell lung cancer -- Commercial availability achieved within two months of announcing MENA ...
MedPage Today on MSN
Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer
Responses observed in patients with and without previous exposure to other KRAS G12C inhib ...
Dietitian Stephanie Meyers shared practical strategies at the LiveLung SCLC Patient Summit to help patients manage appetite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results